Related Experiment Videos
Minimally invasive direct coronary artery bypass
Singapore Medical Journal
|July 22, 1999
Summary
Minimally invasive cardiac surgery, or MIDCAB, offers a promising approach for coronary artery disease. Early results show no mortality or major morbidity, with a short hospital stay, but require longer follow-up.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Techniques
Background:
- Coronary artery disease (CAD) treatment is evolving with minimally invasive approaches.
- Minimally invasive cardiac surgery offers reduced morbidity through smaller incisions.
Purpose of the Study:
- To evaluate the early outcomes of the Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) procedure.
- To assess the feasibility and safety of MIDCAB for treating coronary artery disease.
Main Methods:
- Ten MIDCAB procedures were performed between November 1995 and February 1997.
- The left internal mammary artery was used to bypass the left anterior descending coronary artery (LAD) via a limited left anterior thoracotomy.
- Cardiopulmonary bypass was utilized in the initial two cases, with two patients requiring conversion to conventional surgery.
Main Results:
- No mortality or major morbidity was observed in the study cohort.
- The average post-operative hospital stay was seven days.
- Post-operative angiography in three patients confirmed the patency of the left internal mammary artery to LAD anastomosis.
Conclusions:
- The early results of the MIDCAB procedure are encouraging for treating coronary artery disease.
- Further long-term follow-up is necessary to establish the definitive role of MIDCAB in clinical practice.